Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double blind placebo-controlled trial of Creon in patients with low faecal pancreatic elastase
2011-006019-73Phase 4Terminated
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Sep 2012
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancreatin in exocrine pancreatic insufficiency (EPI), diarrhea, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Sep 2012; status: terminated.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)diarrhea
Beyond the preview
Go deeper on 2011-006019-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006019-73.